All In MedTech

Device Trial Radar · NCT05037968

MagnetOs Flex Matrix Compared to Trinity Elite Mixed With Local Autograft in Patients Undergoing up to Four-level Instrumented Posterolateral Fusion

A Prospective, Randomized, Multi-center Study to Assess the Performance of MagnEtOs Flex Matrix Mixed With Local Autograft Compared to Trinity Elite Mixed With Local Autograft in Patients Undergoing up to Four-level Instrumented poSterolatEral Lumbar/Thoraco-lumbar Fusion (PLF)

Last checked: Nov 19, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 100 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Jun 10, 2024

Primary completion

Dec 2026

Study completion Dec 2026

Sponsor

Lead sponsor
Kuros Biosurgery AGNot on our public-company list
Sponsor type
Industry
Collaborators
Kuros BioSciences B.V.
First posted
Sep 8, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a phase IV post-marketing study for MagnetOs Flex Matrix. MagnetOs Flex Matrix is a synthetic bone graft extender product that is routinely used by surgeons as a treatment for patients with degenerative disc disease and undergoing spinal fusion surgery. In this study, MagnetOs Flex Matrix will be used according to the latest U.S. Instructions For Use, specifically as a bone graft extender mixed with autograft in a 1:1 vol.% in the posterolateral spine. Trinity Elite will also be used according to its latest IFU approved in the US. Specifically, this cellular based allograft is an allograft intended for the treatment of musculoskeletal defects.

Conditions

  • Degenerative Disc Disease
  • Spine Fusion
  • Leg Pain and/or Back Pain

Interventions

  • MagnetOs Flex MatrixDevice

    Procedure: Instrumented Posterolateral Lumbar Fusion

  • Trinity EliteDevice

    Procedure: Instrumented Posterolateral Lumbar Fusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Radiographic Fusion by CT ScanTime frame: Month 12

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • Hartford Hospital

    Hartford, Connecticut · Recruiting

  • Central CT Neurosurgery & Spine

    New Britain, Connecticut · Recruiting

  • Rush University Medical Center

    Chicago, Illinois · Recruiting

6 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.